Table 1_Persistence, chronicity, and recurrence of infection-associated urticaria followin

A systematic review of evidence on long-term outcomes of infection-associated urticaria following viral infections in children and adults, published on 2026-05-26. The review includes five studies involving 596 participants, synthesizing findings on persistence, recurrence, and progression to chronic disease. It was conducted by Saad Alhumaid in accordance with PRISMA 2020 guidelines and registered in PROSPERO.

Use Cases

• Assessing rates of chronic urticaria progression based on reported persistence beyond 6 months and 1 year.
• Comparing recurrence patterns of urticaria based on narrative synthesis of rates ranging from 7% to 30%.
• Investigating risk factors for delayed-onset urticaria based on the described association with SARS-CoV-2 infection.

Strengths

• Includes data from 596 participants across five studies, providing a quantitative basis for review.
• Follows PRISMA 2020 systematic review guidelines and is prospectively registered (CRD420261319656), indicating a structured methodology.
• Explicitly reports key outcome metrics, such as persistence beyond 6 months in up to 9.5% of cases.

Limitations

• Row count and column-level documentation are absent; field semantics must be inferred after download.
• The review notes evidence is limited by heterogeneous study designs, mixed aetiologies, and inconsistent pathogen-specific reporting.
• The dataset is a 230.6 KB DOCX file, indicating a limited scope focused on review text rather than raw patient data.

Provenance

Source

figshare, authored by Saad Alhumaid.

Collection Method

Systematic literature review of databases (PubMed, Embase, CINAHL, Scopus, Web of Science) from inception to 17 March 2026.

Time Range

Literature search covered from database inception to 17 March 2026.

Freshness

Last updated 2026-05-26 06:03:37; freshness should be verified.